Emmaus Life Sciences EMMA
OTC EMMA
$0.06 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Emmaus Life Sciences (EMMA) Cost of Revenue (2010 - 2026)

Updated

Emmaus Life Sciences (EMMA) posted Cost of Revenue of $344,000 for Q2 2026, up 129.3% from $150,000 a year earlier and up 104.8% from the prior quarter.

Analysis

Emmaus Life Sciences (EMMA) Cost of Revenue (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cost of Revenue at Emmaus Life Sciences was $994,000, down 7.8% year-over-year; for FY2025, it was $857,000, down 28.6% from FY2024.

  • Annual Cost of Revenue has declined for four consecutive years, with a five-year compound annual growth rate of -17.5% (FY2020 to FY2025).
  • In prior years, Emmaus Life Sciences' Cost of Revenue was $1.2 million in FY2024 (-10.5%), $1.34 million in FY2023 (-48.1%), $2.59 million in FY2022 (-21.9%) and $3.31 million in FY2021 (+47.3%).
  • The Q2 2026 figure stands as the highest quarterly Cost of Revenue since Q3 2024.
  • On a year-over-year basis, Cost of Revenue increased in three of the last eight quarters, with growth averaging 17.3%.
  • The strongest year-over-year quarter for Cost of Revenue in the past five years was Q4 2021, with growth of 138.2%; the weakest was Q4 2023, with a decline of 70.4%.
  • According to Business Quant data, Cost of Revenue for the three prior quarters was $168,000 (Q1 2026), $235,000 (Q4 2025) and $247,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Emmaus Life Sciences 4.21 Mn -2.09 Mn 5.97 Mn 344,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 344,000.00
Mar 31, 2026 168,000.00
Dec 31, 2025 235,000.00
Sep 30, 2025 247,000.00
Jun 30, 2025 150,000.00
Mar 31, 2025 225,000.00
Dec 31, 2024 309,000.00
Sep 30, 2024 394,000.00
Jun 30, 2024 241,000.00
Mar 31, 2024 257,000.00
Dec 31, 2023 191,000.00
Sep 30, 2023 214,000.00
Jun 30, 2023 508,000.00
Mar 31, 2023 429,000.00
Dec 31, 2022 645,000.00
Sep 30, 2022 540,000.00
Jun 30, 2022 396,000.00
Mar 31, 2022 1.01 Mn
Dec 31, 2021 2.00 Mn
Sep 30, 2021 445,000.00
API Access

Emmaus Life Sciences Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=EMMA&period=max&api_key=YOUR_API_KEY